HGF and neoplasm: The HGF-dependent phosphor-rylation of the MET receptor is correlated with an enhanced potential of malignant cell migration and invasion[37], introducing this pathway as a remarkable therapeutic target for the suppression of invasion and the spread of tumor cells.